2028年までの欧州脳腫瘍診断市場予測 - 新型コロナウイルス感染症の影響と診断タイプ別の地域分析(画像検査、腰椎穿刺、生検、分子検査など)。がんの種類(聴神経腫、星状細胞腫、頭蓋咽頭腫、神経節神経腫、多形膠芽腫、髄膜腫、上衣腫など);エンドユーザー (病院、専門クリニック、外来手術センターなど)

TIPRE00025898 | Pages: 161 | Medical Device | Nov 2021 | Type: Regional | Status: Published

市場紹介

脳がんは、腫瘍を引き起こす脳内の細胞の細胞外増殖によって引き起こされます。腫瘍には原発性脳腫瘍と続発性脳腫瘍が含まれます。原発性脳腫瘍は脳内で形成され、体の他の部分には広がりませんが、二次腫瘍(転移とも呼ばれます)は体の別の部分で発生したがんです。 脳腫瘍は 40 の主要なタイプに分類され、さらに 2 つの主要なグループに分類されます。1 つは良性、つまり成長が遅く転移する可能性が低いもの、悪性、つまり癌性で転移する可能性が高いものです。

< p>したがって、脳腫瘍の有病率の増加により、今後数年間で脳腫瘍診断に対する大きな需要が生み出されると予想され、それがさらに脳腫瘍診断市場を牽引すると予想されます。

がん患者は、これらの人々の多くは免疫抑制があり、高齢である可能性があるため、新型コロナウイルス感染症のパンデミック中に悪影響を受けています。さらに、世界中の多くの診療所でがんの経過観察や画像検査の予約が遅れています。定期的なスクリーニング検査の延期は、新たながんの診断に遅れをもたらします。クリニックは引き続き、新型コロナウイルス感染症(COVID-19)の地域的な発生状況に基づいて、予約スケジュールを監視し、調整しています。がん患者を対象とした新型コロナウイルス感染症に関する研究は限られているが、この集団がより重篤な新型コロナウイルス感染症のリスクにさらされていることを一貫して示している。最近の研究データは、小児がん患者は成人に比べて重症の新型コロナウイルス感染症のリスクが低いことも示唆している。肺、脳、消化管の画像検査によって検出される SARS-CoV-2 感染の特定の特徴は、放射線科医を混乱させる可能性があります。がんの診断、病期分類、治療反応の解釈。最後に、診療所が通常の診察を再開し始めるにつれ、来院中の患者の SARS-CoV-2 曝露を減らすためのプロトコルが導入されました。このレビューでは、新型コロナウイルス感染症のパンデミックががん患者およびがん画像に与える影響について、さまざまな視点から詳しく説明します。

 

市場の概要とダイナミクス

欧州の脳腫瘍診断市場は、2021 年の 2 億 750 万米ドルから 601.0 米ドルに成長すると予想されています2028年までに100万人。 2021 年から 2028 年にかけて 16.4% の CAGR で成長すると推定されています。人工知能には、通常は人間の知能に関連するタスクを実行する強力なコンピューターの使用が含まれます。ディープラーニングと呼ばれる人工知能の一種は、複雑な数学的アルゴリズム (畳み込みニューラル ネットワークとも呼ばれます) を使用してデータから特徴を抽出し、それらを「トレーニング」します。このトレーニングにより、アルゴリズムがパターンを認識し、画像分析などのタスクを実行できるようになります。 SRH イメージャーの強力な機能と AI を組み合わせるために、研究者らは、SRH によって生成された脳腫瘍組織画像に対してアルゴリズム トレーニングを実行し始めました。研究者らは、人工知能技術と病理医が相互に検証できる能力は、病理医が人工知能技術と協力して困難な症例を解釈し、可能な限り最高の診断精度を確保する必要性を浮き彫りにしていると指摘した。 SRH と AI イメージングはどちらも新興テクノロジーであるため、ヘルスケアに統合するのは困難です。 AI テクノロジーにより、外科医は腫瘍や健康な組織を含む領域を迅速かつ正確に特定できるようになります。したがって、手術中の脳腫瘍の診断を強化するために、SRH (人工知能) の使用が増えています。    

 

主要市場セグメント

診断の種類に関しては、画像検査セグメントは、2020年のヨーロッパの脳腫瘍診断市場で最大のシェアを占めました。がんの種類に関しては、多形神経膠芽腫セグメントが2020年のヨーロッパの脳腫瘍診断市場で最大のシェアを占めました。エンドユーザーの観点からは、病院セグメントは、2020 年のヨーロッパの脳腫瘍診断市場で最大のシェアを占めました。

 

>記載されている主要な情報源と企業

ヨーロッパの脳腫瘍診断市場に関するこのレポートを作成するために参照されたいくつかの主要な一次および二次情報源は、企業のウェブサイトです。報告書、財務報告書、国家政府文書、統計データベースなど。このレポートに記載されている主要企業は、Thermo Fisher Scientific Inc.、Siemens Healthineers A、GE Healthcare、Biocept, Inc.、Koninklijke Philips NV、Canon Medical Systems、Hitachi, Ltd.、Neusoft Medical Systems です。

 

理由レポートを購入する

  • ヨーロッパの脳腫瘍診断市場の状況を理解し、強力な成長を保証する可能性が最も高い市場セグメントを特定する戻る
  • ヨーロッパの脳腫瘍診断市場の絶え間なく変化する競争環境を理解し、競争に先んじる
  • ヨーロッパの脳腫瘍診断市場を特定して、M&Aおよびパートナーシップ取引を効率的に計画する最も売上が見込まれる市場セグメントを特定する
  • ヨーロッパ脳腫瘍診断市場のさまざまなセグメントの市場パフォーマンスを知覚的かつ包括的に分析することで、知識に基づいたビジネス上の意思決定を行うのに役立ちます
  • ヨーロッパ地域における 2021 年から 2028 年の市場をさまざまなセグメント別に分析します。

 

ヨーロッパ脳腫瘍診断市場セグメンテーション

 

診断タイプ別

  • 画像検査
    • MRI
    • CT スキャン
    • PET
  • 生検
  • 分子検査
  • 腰椎穿刺
  • その他

 

がんの種類別

  • 多形膠芽腫
  • 星状細胞腫
  • 上衣腫
  • その他

 

エンドユーザーによる

  • 病院
  • 専門クリニック
  • 外来手術センター
  • その他

 

国別

  • ヨーロッパ
    • ドイツ
    • イギリス
    • フランス
    • スペイン
    • イタリア
    • その他のヨーロッパ

 

< Strong>記載されている企業

  1. Thermo Fisher Scientific Inc.
  2. Siemens Healthineers A
  3. GE Healthcare
  4. Biocept 、株式会社
  5. Koninklijke Philips NV
  6. キヤノン メディカル システムズ
  7. 日立製作所
  8. Neusoft Medical Systems

 

 

 

TABLE OF CONTENTS

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2          Brain Cancer Diagnostics Market – By Cancer Type

1.3.3          Brain Cancer Diagnostics Market – By End User

1.3.4          Europe Brain Cancer Diagnostics Market – By Country

2.           Europe Brain Cancer Diagnostics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Europe Brain Cancer Diagnostics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Brain Cancer Diagnostics Market- Europe PEST Analysis

4.3          Expert Opinion

5.           Europe Brain Cancer Diagnostics Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increase in Prevalence of Brain Cancer

5.1.2          Rise in Number of Cigarette Smokers

5.2          Market Restraints

5.2.1          High Cost of Diagnosis

5.3          Future Trends

5.3.1          Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4          Impact Analysis

6.           Brain Cancer Diagnostics Market – Europe Analysis

6.1          Europe Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7.           Europe Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1          Overview

7.2          Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3          Imaging Tests

7.3.1          Overview

7.3.2          Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3          MRI

7.3.3.1             Overview

7.3.3.2             MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4          CT Scan

7.3.4.1             Overview

7.3.4.2             CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5          Positron emission tomography (PET)

7.3.5.1             Overview

7.3.5.2             Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Lumbar Puncture

7.4.1          Overview

7.4.2          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Biopsy

7.5.1          Overview

7.5.2          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Molecular Testing

7.6.1          Overview

7.6.2          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7          Others

7.7.1          Overview

7.7.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1          Overview

8.2          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3          Astrocytomas

8.3.1          Overview

8.3.2          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Glioblastoma Multiforme

8.4.1          Overview

8.4.2          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Ependymomas

8.5.1          Overview

8.5.2          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6          Others

8.6.1          Overview

8.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Brain Cancer Diagnostics Market Analysis – By End user

9.1          Overview

9.2          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3          Hospitals

9.3.1          Overview

9.3.2          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4          Specialty Clinics

9.4.1          Overview

9.4.2          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5          Ambulatory Surgical Centers

9.5.1          Overview

9.5.2          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6          Others

9.6.1          Overview

9.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1        Europe: Brain Cancer Diagnostics Market Revenue and Forecasts to 2028

10.1.1        Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

10.1.2        UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1          UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2          UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.2.2.1           UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.2.3          UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.2.4          UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.3        Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.3.1          Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.3.2          Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.3.2.1           Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.3.3          Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.3.4          Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.4        France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.4.1          France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.4.2          France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.4.2.1           France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.4.3          France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.4.4          France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.5        Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.5.1          Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.5.2          Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.5.2.1           Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.5.3          Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.5.4          Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.6        Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.1          Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.2          Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.6.2.1           Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.6.3          Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.6.4          Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.7        Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.7.1          Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.7.2          Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.7.2.1           Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.7.3          Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.7.4          Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11.        Impact Of COVID-19 Pandemic on Europe Brain Cancer Diagnostics Market

11.1        Europe: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1        Overview

12.2        Growth Strategies Done by the Companies in the Market, (%)

12.1        Organic Developments

12.1.1        Overview

12.2        Inorganic Developments

12.2.1        Overview

13.        Company Profiles

13.1        THERMO FISHER SCIENTIFIC INC.

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        Siemens Healthineers AG

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        GE Healthcare

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        Biocept, Inc.

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        Koninklijke Philips N.V.

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        Canon Medical Systems

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

13.7        Hitachi, Ltd.

13.7.1        Key Facts

13.7.2        Business Description

13.7.3        Products and Services

13.7.4        Financial Overview

13.7.5        SWOT Analysis

13.7.6        Key Developments

13.8        Neusoft Medical Systems

13.8.1        Key Facts

13.8.2        Business Description

13.8.3        Products and Services

13.8.4        Financial Overview

13.8.5        SWOT Analysis

13.8.6        Key Developments

14.        Appendix

14.1        About the Insight Partners

14.2        Glossary of Terms

 


LIST OF TABLES

Table 1.              UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type US$ Mn)

Table 2.              UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test US$ Mn)

Table 3.              UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 4.              UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 5.              Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 6.              Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 7.              Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 8.              Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 9.              France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 10.            France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 11.            France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 12.            France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 13.            Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 14.            Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 15.            Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 16.            Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 17.            Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 18.            Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 19.            Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by Cancer Type (USD Million)

Table 20.            Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by End User (USD Million)

Table 21.            Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 22.            Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 23.            Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 24.            Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 25.            Organic Developments in the Brain Cancer Diagnostics Market

Table 26.            Inorganic Developments in the Brain Cancer Diagnostics Market

Table 27.            Glossary of Terms, Brain Cancer Diagnostics Market

 


LIST OF FIGURES

Figure 1.            Brain Cancer Diagnostics Market Segmentation

Figure 2.            Europe Brain Cancer Diagnostics Market Overview

Figure 3.            Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4.            Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Brain Cancer Diagnostics Market - Europe PEST Analysis

Figure 6.            Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7.            Europe Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9.            Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.          MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18.          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23.          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.          Europe: Brain Cancer Diagnostics Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 28.          Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

Figure 29.          UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30.          Germany Brain Cancer Diagnostics Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.          France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32.          Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.          Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34.          Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 35.          Impact of COVID-19 Pandemic in European Country Markets

Figure 36.            Growth Strategies Done by the Companies in the Market, (%)
  1. Thermo Fisher Scientific Inc.
  2. Siemens Healthineers A
  3. GE Healthcare
  4. Biocept, Inc.
  5. Koninklijke Philips N.V
  6. Canon Medical Systems
  7. Hitachi, Ltd.
  8. Neusoft Medical Systems
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe brain cancer diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000